Intra-Cellular Therapies
ITCI
#1844
Rank
โ‚น751.30 B
Marketcap
โ‚น7,087
Share price
-0.81%
Change (1 day)
19.07%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: โ‚น751.30 Billion

As of January 2025 Intra-Cellular Therapies has a market cap of โ‚น751.30 Billion. This makes Intra-Cellular Therapies the world's 1844th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น751.30 B-2.64%
2024โ‚น771.69 B34.49%
2023โ‚น573.79 B38.36%
2022โ‚น414.72 B30.68%
2021โ‚น317.35 B69.59%
2020โ‚น187.12 B37.79%
2019โ‚น135.80 B210.64%
2018โ‚น43.71 B-13.36%
2017โ‚น50.46 B13.73%
2016โ‚น44.36 B-71.24%
2015โ‚น154.26 B367.5%
2014โ‚น32.99 B20.52%
2013โ‚น27.38 B

End of Day market cap according to different sources

On Jan 8th, 2025 the market cap of Intra-Cellular Therapies was reported to be:

โ‚น751.30 Billion
by Nasdaq info icon info icon
โ‚น751.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น8.37 B-98.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.51 B-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น140.74 B-81.27%๐Ÿ‡บ๐Ÿ‡ธ USA